When dendritic cells (DCs) encounter signals associated with infection or inflammation, they become activated and undergo maturation. Mature DCs are very efficient at presenting antigens captured in association with their activating signal but fail to present subsequently encountered antigens, at least in vitro. Such impairment of MHC class II (MHC II) antigen presentation has generally been thought to be a consequence of down-regulation of endocytosis, so it might be expected that antigens synthesized by the DCs themselves (for instance, viral antigens) would still be presented by mature DCs. Here, we show that DCs matured in vivo could still capture and process soluble antigens, but were unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves was also severely impaired. Indeed, i.v. injection of pathogen mimics, which caused systemic DC activation in vivo, impaired the induction of CD4 T cell responses against subsequently encountered protein antigens. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T cell activation. The biochemical mechanism underlying this phenomenon was the down-regulation of MHC IIpeptide complex formation that accompanied DC maturation. These observations have important implications for the design of prophylactic and therapeutic DC vaccines and contribute to the understanding of the mechanisms causing immunosuppression during systemic blood infections. 2). In their immature state, DCs are highly endocytic and express low amounts of MHC II molecules on their plasma membrane. Pathogenassociated compounds such as those recognized by Toll-like receptors (TLRs) activate immature DCs, which then undergo dramatic phenotypic changes that culminate in the acquisition of a ''mature'' phenotype. Mature DCs down-regulate macropinocytosis and phagocytosis, although they retain their micropinocytic activity (3, 4). Mature DCs accumulate long-lived surface MHC II-peptide complexes, derived from antigens contained within the endosomal compartments at the time of activation (5-10, 55). Such antigens correspond to proteins captured from the extracellular medium (exogenous), or those synthesized by the DCs themselves (endogenous). The latter include components of the endocytic route, plasma membrane proteins, and even cytosolic proteins transferred to endosomal compartments by autophagocytosis (1). Down-regulation of MHC II-peptide complex turnover allows long-term presentation of antigens captured, or synthesized, at the time of activation (''antigenic memory'') (2).Once DCs mature, they lose their capacity to present newly encountered antigens (2). This is usually attributed to downregulation of endocytosis, but it is unclear whether other factors downstream of antigen uptake also contribute to poor presentation of new antigens. It is also i...